Board Member and Audit Chair @ Helix Acquisition Corp. (Nasdaq: HLXA; SPAC merged with Moonlake Therapeutics)
Board Member, Audit Committee Chair, and Nominating and Governance Committee Member @ Neos Therapeutics (Merged with Aytu)
Board Member and Audit Committee Chair @ Patara Pharma, LLC (Acquired by Roivant)
John Schmid's Education
Wesleyan University
Bachelors
1981 - 1985
University of San Diego
MBA
1990 - 1992
Orono High School
1977 - 1981
John Schmid's Skills
Biotechnology
Life Sciences
Start-ups
Financial Modeling
Investor Relations
Venture Capital
Financial Analysis
Lifesciences
Mergers
IPO
John Schmid's Summary
John Schmid, based in Rancho Santa Fe, CA, US, is currently a Board Member and Audit Chair at Helix Acquisiton Corp. II (Nasdaq: HLXB), bringing experience from previous roles at Design Therapeutics (Nasdaq: DSGN), Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), Poseida Therapeutics, Inc. (Nasdaq: PSTX) and AnaptysBio (Nasdaq: ANAB). John Schmid holds a 1981 - 1985 Bachelors @ Wesleyan University. With a robust skill set that includes Biotechnology, Life Sciences, Start-ups, Financial Modeling, Investor Relations and more, John Schmid contributes valuable insights to the industry. John Schmid has 4 emails and 1 mobile phone number on RocketReach.